Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference60 articles.
1. Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives;Lee;Cancer,2011
2. Philadelphia chromosome-positive acute lymphoblastic leukemia;Ravandi;Hematol/Oncol Clin N. Am,2009
3. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis;Gleissner;Blood,2002
4. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia;Kantarjian;J Clin Oncol Off J Am Soc Clin Oncol,2000
5. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial;Moorman;Blood,2007
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia;Pathology;2024-08
2. Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome;Anticancer Research;2024-03-27
3. Temporal changes in survival among adult patients with acute lymphoblastic leukemia diagnosed in the period 1998-2020 – A Danish nationwide population-based study;2023-12-14
4. Treatment de-escalation in Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens;Therapeutic Advances in Hematology;2023-01
5. Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial;The Lancet Haematology;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3